Axial Spondyloarthritis
Axial spondyloarthritis (AS) is a form of inflammatory arthritis that primarily affects the spine and pelvis, leading to pain and stiffness in the back and hips, especially in the morning or after periods of inactivity.
Axial Spondyloarthritis: Risankizumab Treatment
We are studying the effects of a new treatment for patients with very early axial spondyloarthritis. The goal is to see if it can reduce disease activity and improve overall function.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 40 years old?
- Do you have a diagnosis of very early axSpA (ankylosing spondylitis) with symptoms lasting at least 3 months but less than 2 years?
- Do you currently have active disease with significant spinal pain?
- Have you had problems with at least 2 NSAIDs (like Ibuprofen or Naproxen) that didn't help your pain?
- Are you pregnant, breastfeeding, or planning to become pregnant during the study?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
Rheumazentrum Ruhrgebiet
Herne, Germany
Sponsor: St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.